BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Coagulation
,
Ischemia
,
Pancreas
,
Laryngoscope
,
Lipopolysaccharide
,
rs7903146
,
PRKCA
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Tremelimumab
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Tremelimumab: First Approval.
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequen…
Exposure-Response Analyses of Tremelimumab Monotherapy or in Combination with Durvalumab in Patients…
Tremelimumab: A Review in Advanced or Unresectable Hepatocellular Carcinoma.
Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Durvalumab and Tremelimumab for Pediatric Malignancies
Durvalumab, Tremelimumab + Radiotherapy in Gynecologic Cancer
TheraSphere With and Without Durvalumab and Tremelimumab for HCC
Tremelimumab With Chemoembolization or Ablation for Liver Cancer
SGI-110 Plus Durvalumab/Tremelimumab in SCLC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ